Senzime establishment and first TetraGraph-system order in Germany

Press release: Uppsala, January 14, 2021. Senzime AB (publ) today announces the establishment of a German subsidiary, the recruitment of a Country Manager and the first TetraGraph-system order from the University clinic Katholisches Klinikum Bochum.

Breakthrough order from a leading academic medical center in the United States

Press release: Uppsala, December 30, 2020. Senzime AB (publ) today announces that Senzime Inc. has received a breakthrough order from one of the nation’s leading academic healthcare centers, ranked in the Top 10 for quality in the nation.

Senzime granted US Patent for OnZurf Probe

Press release: Uppsala, December 23, 2020. Senzime AB (publ) today announces that the company’s Patent application has been allowed for issuance as a patent for OnZurf Probe in the US. OnZurf is a microdialysis probe designed to monitor gastro-intestinal organs such as esophagus, stomach and liver.

Senzime receives TetraSens single-use electrode order from South Korea at a value of more than 1 Million SEK

Press release: Uppsala, December 22, 2020. Senzime AB (publ) today announces that they have received an additional order of TetraSens single-use electrodes from their distributor in South Korea. The order value amounts to more than 1 Million SEK and delivery will take place during December.

Senzime has carried out a directed issue of 4,545,000 shares, raising proceeds of approximately SEK 100 million

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE , IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SWITZERLAND, UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION IN WHICH THE PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE. Press release: Uppsala, 2, December 2020. Senzime AB (publ) (“Senzime” or the “Company”) has successfully completed a directed issue of 4,545,000 shares, at a subscription price of SEK 22 per share, raising proceeds of approximately SEK 100 million (the “Directed Issue”).

Senzime announces intention to carry out a directed issue of approximately SEK 100 million

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE , IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SWITZERLAND, UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION IN WHICH THE PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE. Press release: Uppsala, 2 December 2020.

Senzime announces outcome in employee stock option program, issues 600 000 shares and receives a total of approximately SEK 5.3 million

Press release: Uppsala, November 26, 2020. Senzime AB (publ) announces today that all outstanding employee stock options within the Employee Stock Option Program 2017/2020 (the “Stock Option Program”) and related warrants have been exercised for subscription of shares.

Senzime receives a new order from South Korea on systems and disposable sensors to a value of more than 1 MSEK

Press release: Uppsala, November 25, 2020. Senzime AB (publ) today announces that they have received an additional order of TetraGraph systems and single use electrodes from their distributor in South Korea. The order value amounts to more than 1 MSEK and delivery will take place during December.

Senzime’s Interim report January – September 2020

Press release: Uppsala, November 6, 2020. Senzime AB’s (publ) Interim report for January – September 2020 is now available on the company’s website  www.senzime.com

Nomination Committee in Senzime ahead of the 2021 Annual General Meeting

Press release: Uppsala, 4 November 2020. In accordance with the resolution at the Annual General Meeting of Senzime AB (publ) on May 14, 2020, the three largest shareholders have on 1 September 2020 appointed a Nomination Committee for the 2021 Annual General Meeting.

Senzime out-licenses OnZurf Probe on the European market

Press release: Uppsala, November 2, 2020. Senzime AB (publ) today announces the signing of an out-licensing agreement with the Italian company Moss S.p.A. As a result of the agreement, Moss will assume 10-year manufacturing and sales rights for the OnZurf Probe on the European market. The license agreement is estimated to generate more than SEK 100 million in license royalties over the term.

Senzime expands into the French market driven by new clinical Guidelines

Press release: Uppsala, October 29, 2020. Senzime AB (publ) today announces that the company has entered into an exclusive agreement with The Surgical Company (formerly Sebac) for the French market, and the first order to a university hospital in France is ready to be delivered.  Market entry is driven by the new clinical guidelines in France supporting the use of Senzime’s products in surgery.

Eva Walde strengthens Senzime’s Board of Directors

Press release: Uppsala, October 19, 2020. Senzime announces that Eva Walde is appointed new acting Board Member to be elected at the next shareholder’s meeting.

Senzime's first sales team in the USA in place

Press release: Uppsala, October 13, 2020. Senzime AB (publ) today announces that the company's American subsidiary - with the recruitment of the sixth employee - has reached the first established level of commercial org development in the US, as decided by the Board of Directors.

Senzime receives order from Switzerland

Press release: Uppsala, October 2, 2020. Senzime AB (publ) today announces that the company has received another order from its distributor Leuag in Switzerland. The order of TetraGraph systems with Philips Interface and disposable TetraSens sensors have been purchased to replace the hospitals current AMG systems. The order value amounts to approximately SEK 300 thousand and delivery will take place during the current month.

Senzime communicates strategic and financial goals

Press release: Uppsala, September 23, 2020. Senzime AB (publ) today announces the company’s strategic and financial goals for 2023. 

Senzime secures large order on single use sensors from South Korea

Press release: Uppsala, September 15, 2020. Senzime AB (publ) today announces that the company has received another order from its distributor in South Korea. The order value amounts to approximately SEK 1 million and refers only to single use TetraSens sensors. The order will be processed during the current month.

TetraGraph connects surgical data to the cloud

Press release: Uppsala, August 24th, 2020. Senzime AB (publ) today announces the launch of TetraConnect, a novel cloud-based platform allowing physicians to graphically visualize and share patient data when using the TetraGraph monitor.

Senzime’s Interim report January – June 2020

Press release: Uppsala, August 21, 2020. Senzime AB’s (publ) Interim report for January – June 2020 is now available on the company’s website  www.senzime.com

CEO Pia Renaudin buys shares for SEK 5.5 million in Senzime

Press release: Uppsala, July 17th, 2020. Senzime AB (publ) today announces that CEO Pia Renaudin has acquired 300,000 shares in the company at a price of SEK 18.50 per share, corresponding to a value of approximately SEK 5.5 million. The shares have been acquired from a consortium of principal owners consisting of Segulah Venture AB, Adam Dahlberg and Philip Siberg (through company).

Communique from extra general meeting in Senzime AB (publ)

The extra general meeting in Senzime AB (publ), corp. reg. no 556565-5734 (the “Company”) was held on 2 July 2020 in Uppsala by postal voting in advance whereby the shareholders primarily resolved on the following matters.

Senzime expands US sales team and signs additional distribution agreements

Press release: Uppsala, June 24, 2020. Senzime AB (publ) today announces that the company has initiated its Sales Ramp Up in the US to establish a direct sales force in key territories and that the company has signed distribution agreements for the Midwest and Northwest territories.

Notice of extra general meeting in Senzime AB (Publ)

Press release: Uppsala, June 18, 2020. The shareholders in Senzime AB (publ) corp. reg. no 556565-5734 (the “Company”) are hereby convened to an extra general meeting on Thursday 2 July 2020 in Uppsala. The extra general meeting will be carried out solely through advance postal voting due to the Corona pandemic (Covid-19). This means that the shareholders in the Company may not attend to the general meeting in person nor to be represented by proxy. The shareholders may exercise their voting rights at the general meeting through postal voting in accordance with the instructions in this notice of extra general meeting.

Communique from annual general meeting in Senzime AB (publ)

The annual general meeting in Senzime AB (publ), corp. reg. no 556565-5734 (the “Company”) was held on 14 May 2020 at Green Innovation Park’s premises on Ulls väg 29C in Uppsala whereby the shareholders primarily resolved on the following matters.

Senzime’s Interim report January – March 2020

Press release: Uppsala, May 8, 2020. Senzime AB’s (publ) Interim report for January – March 2020 is now available on the company’s webbsite  www.senzime.com

1|2|3|4|5